We are live on ! Find out more
CNBT

Canandaigua National Bank & Trust Portfolio holdings

AUM $1.19B
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$302M
AUM Growth
+$799K
Cap. Flow
+$2.71M
Cap. Flow %
0.9%
Top 10 Hldgs %
31.45%
Holding
194
New
9
Increased
75
Reduced
77
Closed
7

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$721K
2
MCD icon
McDonald's
MCD
+$670K
3
RIG icon
Transocean
RIG
+$657K
4
BNY
Bank of New York Mellon
BNY
+$625K
5
AA icon
Alcoa
AA
+$489K

Sector Composition

Rank Sector Weight
1 Industrials 17.39%
2 Healthcare 13.4%
3 Technology 12.77%
4 Financials 12.51%
5 Energy 11.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
76
Colgate-Palmolive
CL
$73.7B
$989K 0.33%
15,160
+310
+2% +$20.4K
J icon
77
Jacobs Solutions
J
$16.9B
$989K 0.33%
24,494
-931
-4% -$40.6K
STT icon
78
State Street
STT
$52.1B
$955K 0.32%
12,971
-244
-2% -$17.4K
WMT icon
79
Walmart Inc
WMT
$914B
$912K 0.3%
35,793
-420
-1% -$10.6K
MS icon
80
Morgan Stanley
MS
$345B
$894K 0.3%
25,848
-3,095
-11% -$103K
BRK.B icon
81
Berkshire Hathaway Class B
BRK.B
$1.09T
$887K 0.29%
6,424
+845
+15% +$113K
NE
82
DELISTED
Noble Corporation
NE
$861K 0.29%
38,750
-1,195
-3% -$32.2K
EXPD icon
83
Expeditors International
EXPD
$23.4B
$820K 0.27%
20,205
-330
-2% -$14.1K
AXP icon
84
American Express
AXP
$230B
$815K 0.27%
9,305
+150
+2% +$13.5K
AMGN icon
85
Amgen
AMGN
$225B
$762K 0.25%
5,423
+311
+6% +$40.6K
BNDX icon
86
Vanguard Total International Bond ETF
BNDX
$82.9B
$762K 0.25%
14,632
+6,714
+85% +$348K
MO icon
87
Altria Group
MO
$108B
$762K 0.25%
16,597
-375
-2% -$16.1K
TEVA icon
88
Teva Pharmaceuticals
TEVA
$43.3B
$761K 0.25%
14,166
-13,600
-49% -$721K
XRX icon
89
Xerox
XRX
$407M
$757K 0.25%
21,707
+7,886
+57% +$275K
TJX icon
90
TJX Companies
TJX
$170B
$756K 0.25%
25,560
+2,160
+9% +$60.9K
TXN icon
91
Texas Instruments
TXN
$255B
$744K 0.25%
15,607
-50
-0.3% -$2.4K
AET
92
DELISTED
Aetna Inc
AET
$736K 0.24%
9,092
+1,140
+14% +$92.8K
UNP icon
93
Union Pacific
UNP
$174B
$717K 0.24%
6,612
+392
+6% +$40.6K
LLY icon
94
Eli Lilly
LLY
$1.09T
$715K 0.24%
11,018
+25
+0.2% +$1.58K
EMR icon
95
Emerson Electric
EMR
$90.9B
$712K 0.24%
11,378
-690
-6% -$44.8K
GLW icon
96
Corning
GLW
$144B
$651K 0.22%
33,685
+7,175
+27% +$150K
GS icon
97
Goldman Sachs
GS
$305B
$645K 0.21%
3,515
-175
-5% -$30.7K
PM icon
98
Philip Morris
PM
$289B
$628K 0.21%
7,527
-2,150
-22% -$182K
BAX icon
99
Baxter International
BAX
$13.8B
$625K 0.21%
16,031
-323
-2% -$13.1K
AA icon
100
Alcoa
AA
$14B
$619K 0.21%
16,008
-12,473
-44% -$489K

Similar funds

Canandaigua National Bank & Trust's Q3 2014 Portfolio in Review

As of Q3 2014, Canandaigua National Bank & Trust held 194 positions worth $302M, up 0.27% from $301M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Canandaigua National Bank & Trust's Q3 2014 filing shows 9 new, 75 increased, 77 reduced and 7 closed positions. Its largest new stake was Celgene Corp: 13,414 shares worth $1.27M. The largest sale was Teva Pharmaceuticals, an estimated $721K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • Canandaigua National Bank & Trust's largest Q3 2014 buy was Celgene Corp: 13,414 shares worth $1.27M.
  • Canandaigua National Bank & Trust added most to Gilead Sciences in Q3 2014, an estimated $1.08M increase.
  • Canandaigua National Bank & Trust's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $721K.
  • Canandaigua National Bank & Trust fully exited Transocean in Q3 2014, selling an estimated $657K.
  • Canandaigua National Bank & Trust's ten largest holdings make up 31% of its $302M portfolio in Q3 2014.
  • Canandaigua National Bank & Trust opened 9 new positions and closed 7 in Q3 2014.
  • Canandaigua National Bank & Trust's portfolio value rose 0.27% quarter-over-quarter to $302M.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2014, filed 13 Nov 2014.